Evidence map›Paper›PMID 42404482›Full record

ArticleCase reports in otolaryngology2026

Managing Nasal Ischemia and Necrosis Post-Triamcinolone Injection: A New Case Series.

Shahriar Nazari, Nima Hadadian, Foroohe Bayatparidary, Seied Omid Keyhan, Mohammadamin Damsaz, Nabil Fakih-Gomez, Mohammad Reza Pourani

Abstract read
In one paragraph

Article in Case reports in otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shahriar NazariDepartment of ENT and Head and Neck Surgery, BMI Hospital, Tehran, Iran.ORCID https://orcid.org/0009-0006-4283-3125
Nima HadadianPrivate Practice, Zibaban Clinic, Management and Research of Complications Clinic, Tehran, Iran.
Foroohe BayatparidaryPrivate Practice, Zibaban Clinic, Management and Research of Complications Clinic, Tehran, Iran.
Seied Omid KeyhanDepartment of Oral & Maxillofacial Surgery, College of Medicine, University of Florida, Jacksonville, Florida, USA, ufl.edu.
Mohammadamin DamsazMaxillogram Maxillofacial Surgery, Implantology and Biomaterial Research Foundation, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-3757-9573
Nabil Fakih-GomezDepartment of Facial Plastic & Cranio-Maxillo-Facial Surgery, Fakih Hospital, Khaizaran, Lebanon.ORCID https://orcid.org/0000-0003-4464-8258
Mohammad Reza PouraniPrivate Practice, Zibaban Clinic, Management and Research of Complications Clinic, Tehran, Iran.ORCID https://orcid.org/0000-0003-3222-7528

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasal ischemia following cosmetic injections has been reported in several cases. Postsurgery triamcinolone administration in the nasal region is a common practice to reduce inflammation and address pollybeak deformity. While cases of retinal artery occlusion following triamcinolone injection have been documented, this case series presents the first reported instance of nasal necrosis resulting from triamcinolone injection. This article explores the management strategies and therapeutic approaches for ischemia following triamcinolone administration. Four cases of nasal ischemia following triamcinolone injections administered postrhinoplasty are documented. The first case presented a young female who experienced ischemia with involvement of the columellar artery, leading to reduced blood flow in the dorsal and lateral nasal arteries. The remaining cases were patients who sought reconstructive surgery due to nasal necrosis caused by triamcinolone injections. Triamcinolone injection in the nasal region can lead to ischemia. Treatment options should be customized to each patient's condition. The THIS and FAT protocol with toxins (botulinum neurotoxin), high-dose hyaluronidase, and injectable platelet-rich fibrin (iPRF), solid platelet-rich fibrin (sPRF) dressings, and antibiotics as well as hyperbaric oxygen therapy (HBOT) can enhance tissue recovery, minimize scarring, and improve the overall outcome.

Indexed as

nasal ischemianecrosisrhinoplastytriamcinolone

Identifiers

PMID42404482
PMCPMC13329764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.